- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04395209
Muscle Strength Loss In Stroke Individuals - Control Study
May 14, 2020 updated by: Suat EREL, Pamukkale University
ABSTRACT The muscle strength (MS) is necessary to overcome the resistance encountered during the activity.
The present study aims to determine MS loss in stroke individuals (SI).
33 SI and 33 healthy individuals (HI) were included in this study.
MS and handgrip force were assessed using a power track dynamometer and Jamar hand dynamometer, respectively.
The total MS of the HI was calculated by summing the muscle strength of the trunk, lower and upper extremities.
In the SI, the muscle strength of the trunk, unaffected upper and lower extremities were summed to calculate the total MS.
To compare MS of unaffected sides (US) between groups, 27 SI who was dominant and not affected on the right side and 33 HI who was dominant on the right side were used.
Study Overview
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pamukkale
-
Denizli, Pamukkale, Turkey, 20100
- University Address
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- for patient with stroke
- Between 30-65 ages
- Diagnosed with stroke chronic stroke patients (diagnosed with a stroke at least 6 months ago)
for healthy individuals
- 30-65 ages
- healthy individuals
Exclusion Criteria for patient with stroke
- patient with an additional neurological disease to stroke
- patients with orthopedic problems,
- patients with mental and communication impairments
- patients who scored more than 3 points for the Modified Rankin Scale for healthy individuals;
- who had active sporting life
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: stroke individuals
|
muscle strength assessment in stroke individuals
|
Active Comparator: healthy individuals
|
muscle strength assessment in stroke individuals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle Strength Loss In Stroke Individuals - Control Study
Time Frame: 24 week
|
muscle strength of stroke individuals was assesed by power track hand held dynamometer and The Jamar Hand dynamometer, And recorded in newton.
|
24 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 31, 2017
Primary Completion (Actual)
January 16, 2018
Study Completion (Actual)
January 1, 2020
Study Registration Dates
First Submitted
May 12, 2020
First Submitted That Met QC Criteria
May 14, 2020
First Posted (Actual)
May 20, 2020
Study Record Updates
Last Update Posted (Actual)
May 20, 2020
Last Update Submitted That Met QC Criteria
May 14, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pamukkale Uni
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke Rehabilitation
-
Centre d'Investigation Clinique et Technologique...CompletedStroke | Gait | Robotic RehabilitationFrance
-
Medical College of WisconsinMarquette UniversityCompletedStroke Rehabilitation | Ischemic Preconditioning | Physical and Rehabilitation MedicineUnited States
-
National Taiwan University HospitalRecruiting
-
University Hospital, LimogesRecruiting
-
University Hospital of FerraraIstituto Italiano di TecnologiaCompletedStroke RehabilitationItaly
-
Reuth Rehabilitation HospitalCompleted
-
Muş Alparlan UniversityNot yet recruitingSTROKE REHABİLİTATİONTurkey
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruiting
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...RecruitingStroke RehabilitationTaiwan
-
National Taiwan University HospitalCompletedStroke RehabilitationTaiwan
Clinical Trials on assesment
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Sanko UniversityCompletedMultiple Sclerosis | Balance; Distorted | Walking, DifficultyTurkey
-
Marmara UniversityCompleted
-
Cairo UniversityCompleted
-
Kahramanmaras Sutcu Imam UniversityNot yet recruiting
-
Harran UniversityCompletedSurgery--Complications | Arthropathy | Physical DisabilityTurkey
-
Necmettin Erbakan UniversityCompletedIdiopathic Polyhydramios CasesTurkey
-
University Hospital, LilleCompleted
-
University Hospital, LilleCompletedOsteoporosis | Sars-CoV2France
-
Nepal Mediciti HospitalCompletedSafety Issues | Patient Acceptance of Health CareNepal